Integrative analysis of bulk RNA transcriptomics and prostate health index identifies molecular signatures for prostate cancer in an Asian cohort.

This dataset contains bulk RNA-sequencing data from 19 prostate tissue samples obtained from an Asian cohort, comprising five benign controls, five low-grade prostate cancer samples, and nine high-grade prostate cancer samples. Transcriptomic profiles were analyzed in relation to prostate cancer grade, prostate-specific antigen (PSA), and Prostate Health Index (PHI).